February 27, 2019
Roche Diagnostics said on February 26 that it has applied for Ventana OptiView PD-L1 (SP142), a pathology test kit used to assess PD-L1 expression, seeking its use in breast cancer patients in Japan. This filing comes after Chugai Pharmaceutical submitted...read more